Clinical Trial Update: Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update announces completion of Phase 1/2 evaluation of INZ-701 in adults with ENPP1 deficiency, assessing safety, tolerability, and potentia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Recessive Hypophosphatemic Rickets
• Enpp1 Deficiency
• Generalized Arterial Calcification of Infancy

Drugs mentioned

• INZ-701

Snippet

Sponsor: Inozyme Pharma | Conditions: Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets | Phase 1, Phase 2 | Status: COMPLETED